提炼
我们感谢Fromme和Strnad的医生[1]所表现出的兴趣和重要意见。以前已知患有严重α-1-抗抗蛋白酶缺乏症(AATD)的人患有肝癌在内的肝病的风险增加[2,3]。除了研究肝癌的风险外,我们在最近发表的文章[4]中的主要目的是评估开发其他类型的癌症(非肝癌)的风险。我们感谢Fromme和Strnad提供的有关肝细胞癌的知识的最新摘要。我们强烈同意在严重AATD的患者中进行定期监测,以进行肝细胞癌的发展。在瑞典,患有严重AATD的个体经常(每2年)随访肝酶,但没有肝脏或肝脏超声检查[5]。
Footnotes
This manuscript has recently been accepted for publication in the欧洲呼吸杂志。它在我们的生产团队复制和排版之前以其公认的形式出版。在完成这些生产过程并批准了由此产生的证明之后,该文章将转移到最新一期ERJonline. Please open or download the PDF to view this article.
Conflict of Interest: Anne Lindberg reports lecture honoraria from Boehringer Ingelheim, Novartis; personal fees for advisory board participation with AstraZeneca, GlaxoSmithKline, Novartis, Boehringer Ingelheim; outside the submitted work. All other authors have nothing to disclose.
- Received2022年4月6日。
- 公认April 22, 2022.
- Copyright ©The authors 2022. For reproduction rights and permissions contact权限{at} ersnet.org
库用户
通过您的机构登录
If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
如果您的组织使用OpenAthens,则可以使用OpenAthens用户名和密码登录。To check if your institution is supported, please seethis list。Contact your library for more details.
如果您认为应该访问,请联系您的图书馆员或电子邮件journals@ersnet.org
Purchase access
您可以购买本文的访问权限。如果您还没有一个帐户,这将需要您创建一个帐户。